Chronic CNS oxytocin signaling preferentially induces fat loss in high-fat diet-fed rats by enhancing satiety responses and increasing lipid utilization
- 1 April 2016
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 310 (7) , R640-R658
Abstract
Based largely on a number of short-term administration studies, growing evidence suggests that central oxytocin is important in the regulation of energy balance. The goal of the current work is to determine whether long-term third ventricular (3V) infusion of oxytocin into the central nervous system (CNS) is effective for obesity prevention and/or treatment in rat models. We found that chronic 3V oxytocin infusion between 21 and 26 days by osmotic minipumps both reduced weight gain associated with the progression of high-fat diet (HFD)-induced obesity and elicited a sustained reduction of fat mass with no decrease of lean mass in rats with established diet-induced obesity. We further demonstrated that these chronic oxytocin effects result from 1) maintenance of energy expenditure at preintervention levels despite ongoing weight loss, 2) a reduction in respiratory quotient, consistent with increased fat oxidation, and 3) an enhanced satiety response to cholecystokinin-8 and associated decrease of meal size. These weight-reducing effects persisted for approximately 10 days after termination of 3V oxytocin administration and occurred independently of whether sucrose was added to the HFD. We conclude that long-term 3V administration of oxytocin to rats can both prevent and treat diet-induced obesity.Keywords
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK-095980, HL-091333, HL-107256, 2T32DK007247, HL-107256, HL-107256, 2T32DK007247, P30 DK035816, P30DK017047)
- U.S. Department of Veterans Affairs (VA) (1 I01 BX001213-01A1, VA Senior Research Career Scientist)
This publication has 106 references indexed in Scilit:
- Treatment of Obesity and Diabetes Using Oxytocin or Analogs in Patients and Mouse ModelsPLOS ONE, 2013
- Involvement of Prolactin‐Releasing Peptide in the Activation of Oxytocin Neurones in Response to Food IntakeJournal of Neuroendocrinology, 2013
- FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesisGenes & Development, 2012
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesisNature, 2012
- Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatmentAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Fructose-Fed Rhesus Monkeys: A Nonhuman Primate Model of Insulin Resistance, Metabolic Syndrome, and Type 2 DiabetesClinical and Translational Science, 2011
- Subchronic treatment of rats with oxytocin results in improved adipocyte differentiation and increased gene expression of factors involved in adipogenesisBritish Journal of Pharmacology, 2010
- Energy intake in weight-reduced humansBrain Research, 2010
- Identification of neuronal subpopulations that project from hypothalamus to both liver and adipose tissue polysynapticallyProceedings of the National Academy of Sciences, 2010
- Insulin hypersensitivity in mice lacking the V1b vasopressin receptorThe Journal of Physiology, 2007